Scedosporium apiospermum is an opportunistic fungus in humans. The incidence of S. apiospermum infection in patients with acquired neutropenia (e.g., patients receiving chemotherapy and bone marrow transplant recipients) is steadily increasing. S. apiospermum has poor in vitro susceptibility to ''conventional'' antifungal agents, rendering the management of infections complex. Patients with chronic granulomatous disease (CGD) are highly susceptible to fungal infections, which are mostly due to Aspergillus species. We describe two children with CGD and invasive pulmonary infection due to S. apiospermum. Both patients were treated with antifungal therapy including azole derivatives (itraconazole or voriconazole) and surgical resection of infected tissues. These cases highlight that scedosporium infection can closely mimic aspergillus infection and should be considered in any case in which there is a failure to respond to appropriate ''conventional'' antifungal therapy. We also suggest that the emergence of this pathogen may have been favored by long-term use of amphotericin B in both patients.
Chronic granulomatous disease (CGD) is an inherited disorlar in terms of tissue [8] . The incidence of infections due to Scedosporium in patients with acquired neutropenia (e.g., pader characterized by an impaired respiratory burst of phagocytic cells due to deficient assembly in the NADPH oxidase [1] .
tients receiving chemotherapy and bone marrow transplant recipients) or receiving immunosuppressive treatment (corticoPhagocytosis of microorganisms by neutrophils and monocytes occurs normally, but bacterial and fungal killing by phagocytic steroids and cyclosporin A) has steadily risen in recent years [8 -11] . One important feature of this emerging pathogen is its cells is defective [2] . Patients have recurrent infections beginning in the first year of life that usually involve the skin, resistance to amphotericin B and flucytosine, the former being the ''conventional'' systemic antifungal chemotherapy given lymph nodes, lung, liver, and gastrointestinal tract [3] . Primary prophylaxis with trimethoprim-sulfamethoxazole has been to immunocompromised hosts [10, 11] . shown to be effective in reducing the frequency of bacterial infections in these patients [4] , and IFN-g therapy is used, Case Reports with proven efficacy, for those who are severely affected [5] . However, fungal infections remain a major threat and are the Case 1 leading cause of death in these patients. Aspergillus species An 8-year-old boy with autosomal recessive CGD who had are the most frequently encountered pathogens, and primary deficiency of the 47-kD cytosolic protein p47 phox [2] was admitprophylaxis with itraconazole has been reported to reduce the ted to Hôpital Necker Enfants Malades (Paris) in September incidence of fungal infections [6] .
1995 because of high fever, cough, and tachypnea. He preThe genus Scedosporium has been associated with a wide viously had two invasive pulmonary aspergillus infections in spectrum of infections caused by two species: Scedosporium 1988 and 1993 that were both successfully treated with iv apiospermum (or Pseudallescheria boydii, the perfect stage of amphotericin B (1 mg/[kgrd] for 1 month with progressive the fungus) and Scedosporium prolificans (formerly Scedosportapering over 1 year). ium inflatum) [7] . Scedosporium species are hyaline filamentous At the time of admission, a chest roentgenogram and CT pathogens of the Hyalohyphomycetes class, which also inscan showed the presence of a pulmonary abscess in the left cludes Aspergillus species and Fusarium species. These three lower lobe. The child had elevated inflammatory markers (neupathogens share similar epitopes and are morphologically simitrophil count, 10,000/mm trophoresis) was performed on serum samples collected before and after admission; it was negative 1 year before admission, After 1 month of treatment, extension to the chest wall with evidence of pleural and costal involvement was noted on a CT weakly positive at the time of admission (one band), and highly positive at the time of the pulmonary biopsy (three bands). scan ( figure 1 ). His titer of antibody to Aspergillus had, however, fallen to 1:640, representing a significant drop of three
In vitro activity of antifungal agents against the S. apiospermum spores, tested by a microdilution method determining the dilutions from the level noted at admission. Sputum culture yielded S. apiospermum. Needle biopsy of the left pulmonary MIC of the drug at which there was no visible growth of the isolate [12] , demonstrated that the MICs of amphotericin B infiltrate was then performed and showed the presence of thin (2-3 mm) septate hyphae branched with sharp angles. Culture and flucytosine for the isolate were high (8 mg/mL and 12 mg/mL, respectively). The MICs of miconazole, voriconazole, and itraconazole were 0.3 mg/mL, 0.4 mg/mL, and 0.7 mg/mL, respectively, thus demonstrating their in vitro effectiveness against the isolate. Therapy with iv miconazole (50 mg/[kgrd]) was started but had to be discontinued because of anaphylaxis due to the solvent (chremophor E). Treatment with high doses of oral capsules of itraconazole (30 mg/[kgrd]) was begun but after 15 days had no effect on clinical symptoms (fever, cough, and chest abscess) and biological markers (ESR, neutrophil count, C-reactive protein level, and factor I level). Voriconazole (UK 109-496) was then obtained on the basis of a compassionate protocol from Pfizer Central Research (Sandwich, England), and the child was treated with oral voriconazole (10 mg/[kgrd]) and subcutaneous IFN-g (1.5 mg/[kgrd]). Systemic manifestations resolved, and a CT scan showed a marked improvement after 2 months of treatment. Titers of antibody to Aspergillus and antibody to Scedosporium became negative after 4 months of treatment. After 7 months of treatment, a pulmonary CT scan revealed a residual left pulmonary infiltrate with pleural and costal involvement. Trough and peak serum levels of voriconazole were still within the pharmaceutical range (0.54 mg/mL and 5 mg/mL, respectively). Because of the CT findings, left-sided thoracotomy was performed, and the lower left lobe and the posterior parts of the seventh and eighth left ribs were removed. Histopathologic examination of the lung and rib tissue specimens showed the presence of multiple granulomas filled with periodic acid -Schiff stain -positive pathogens consistent with a persistent fungal infection. Cultures of these specimens were negative.
Treatment with voriconazole was continued for a further 8 months; a 4-month course of IFN-g (1.5 mg/[kgrd]) was added to the therapeutic regimen. One year after surgery, no new lesions were revealed by CT, and serology for Scedosporium was negative. when the child presented with a lower right pulmonary abscess the child was well; serology for Scedosporium was negative, and no new lesions were seen on a CT scan. and a hepatic cavity that were seen on a CT scan. Titers of antibody to Aspergillus, which had previously been negative, were markedly elevated (1:640 determined by ELISA and three Discussion bands revealed by cocounterimmunoelectrophoresis). Ketoconazole prophylaxis was discontinued, and the child received S. apiospermum is the anamorph form of the fungus P. boydii, which is the causative organism of mycetoma [13 - Fifteen months after the initial episode, the child presented pneumonitis and localized infections are most common in immunocompetent patients [9, 22] . A striking parallel exists bewith fever, hemoptysis, and tachypnea while he was still receiving maintenance therapy with amphotericin B (1 mg/kg two tween clinical manifestations of scedosporiosis and those of times a week). A CT scan showed persistence of the lower right pulmonary lesions with a second abscess in the right lung (figure 3). Serology for Aspergillus was negative. In contrast, serology for S. apiospermum was highly positive (four bands revealed by cocounterimmunoelectrophoresis). Retrospective serological analysis for Scedosporium revealed a recent rise in the titer of antibody. Treatment with iv miconazole (50 mg/[kgrd]) was initiated, but no improvement was observed after 15 days.
Right-sided thoracotomy was performed, and both pulmonary abscesses were removed. Histopathologic examination of abscess specimens showed necrotic granulomas with GrocottGomori methenamine -silver nitrate -positive, periodic acidSchiff stain -positive septate hyphae (2 -3 mm), some of which were in a sexually perfect stage compatible with infection due to Scedosporium species (figure 4). No exact identification of the pathogen was possible as culture of the lung specimen was negative probably because of ongoing antifungal therapy. With a combination of high doses of oral capsules Voriconazole is a new azole derivative with a spectrum of antifungal activity against filamentous fungi that is close to that of itraconazole. Its clinical and biological tolerance along with its effectiveness against fungal infections are still under evaluation. A recently reported study demonstrated its potentially high in vitro activity against emerging pathogens including isolates of Scedosporium species [30] . Treatment with these new azole derivatives helped control infection in our patients. However, both patients required surgical resection of pulmonary abscesses. These observations support findings of previously reported studies, which indicate that surgical resection tion effect of which is the emergence of resistant molds. Against this hypothesis is the fact that itraconazole has good in vitro activity against S. apiospermum [27-29], even if results of in vitro testing must be interpreted with caution as no good in vitro or in vivo aspergillosis. Diagnosis of invasive infection is made on the basis of identification of the mold in a standard culture of a correlation has been established. In addition, the relative initial ineffectiveness of itraconazole in case 1 could be because of the biopsy specimen of the infected tissue. Serum testing for antibodies to the pathogen may contribute to the diagnosis, even repeatedly low serum levels of itraconazole before admission (poor absorption of oral capsules and/or noncompliance) and/or because though this technique is not specific enough to diagnose infection due to S. apiospermum. Cross-reactions with Aspergillus the duration of treatment with this agent was too short (15 days). The in vitro activity of ketoconazole against S. apiospermum is and other pathogens and false-negative and false-positive results are possible [23, 24] . However, in patients with CGD, variable [8] [9] [10] [11] . Both patients had previously received treatment for invasive positive serology for Aspergillus is probably a good marker of an ongoing invasive fungal infection.
aspergillus infection with amphotericin B without itraconazole over a long period, which could be another predisposing factor The usefulness of serology for other diseases, including cystic fibrosis (for which it mainly reflects fungal colonization) appears for scedosporiosis. Itraconazole prophylaxis was discontinued with the commencement of amphotericin B therapy because of to be more limited. Serology is performed routinely for children who frequent the outdoors and serves as a baseline test for concern about possible antagonism between the two molecules [31] . The hypothesis that the exclusive use of amphotericin B comparison for patients with symptomatic fungal infection and as an alarm trigger for asymptomatic patients whose serum antipredisposed the patients to these infections is strongly supported by the lack of in vitro activity against most Scedosporbody levels rapidly increase [25] . In case 1, the diagnosis of invasive pulmonary scedosporiosis was made by culture of inium isolates and the poor in vivo therapeutic responses to this agent. Disseminated infection with P. boydii in a patient with fected lung tissue positive for S. apiospermum. In case 2, no definite diagnosis could be made as culture of infected lung CGD has been previously reported [32] . The child responded to treatment with iv miconazole followed by oral ketoconazole tissue did not yield S. apiospermum probably because of treatment with miconazole. However, histological examination of and IFN-g therapy. No data regarding previous treatment of the child with amphotericin B, or other agents, were available. the biopsy specimen and failure of amphotericin B therapy, together with the high titer of antibody to S. apiospermum and It is also possible that the pulmonary aspergillus infections themselves contributed to the development of scedosporium a negative titer of antibody to Aspergillus, strongly argue for invasive pulmonary scedosporiosis in this child.
infection, as infections due to this agent have been reported to develop as sequelae of pulmonary infections due to Aspergillus Treatment guidelines for infections due to Scedosporium are not well established in the literature [8 -11] . S. apiospermum species [13, 24] . These cases highlight that scedosporium infection may is almost invariably resistant in vitro to amphotericin B and flucytosine [8 -11] . Medical cures with azole derivatives have mimic aspergillus infection and should be considered, and looked for, in any case in which appropriate ''conventional'' been attempted. Initially, intravenous miconazole was used; / 9c5c$$de06
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